DCM Nouvelle Limited

NSE:DCMNVL.NS

198.09 (INR) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32016 Q3
Revenue 2,688.82,643.82,668.62,942.72,554.32,365.82,095.21,622.32,560.81,617.512,312.52,409.51,8821,442.9241,523.71,503731.9909.7591,505.31,379.21,562.5-4,876.61,5751,686.61,615000
Cost of Revenue 2,2652,181.22,127.22,429.72,012.31,823.31,752.51,452.71,849.51,935.0461,475.71,361.81,039.51,260.698980.21,148.2535.41,070.3251,0681,0261,119.61,348.4921,090.71,091.91,092.3000
Gross Profit 423.8462.6541.4513542542.5342.7169.6711.3-317.536836.81,047.7842.5182.226543.5354.8196.5-160.566437.3353.2442.9-6,225.092484.3594.7522.7000
Gross Profit Ratio 0.1580.1750.2030.1740.2120.2290.1640.1050.278-0.1960.3620.4350.4480.1260.3570.2360.268-0.1760.2910.2560.2831.2770.3070.3530.324000
Reseach & Development Expenses 0000000000000000000000000000
General & Administrative Expenses 00000000000000000000000000.09200.003
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 328.3333.8311.3320.4147.8285.1228.8167.7123.4139.149123.7166.6285.5258.9103.296.489.6108.419100.3103.6103.799.9796.998.4880.09200.003
Other Expenses 19.214.21413.824.529108.710.6-71.90734.935.87.5-43.56814.518.815.9-43.94913.712.123.2-1,199.57732.624.87000
Operating Expenses 328.3333.8524.2536.5509.7478.7383.8297.1390.9-604.396441.9510.1441.3-146.814377.7344.6269.1-260.773375.2365.2415.2-1,199.577395.1401.6402.90.0240.0040.017
Operating Income 95.5128.831.2-9.732.263.5-31.1-118.8320.4286.86394.9537.6408.7319.846180.329-56.720.79875.80.150.9-401.823121.8217.6126.8-0.019-0.004-0.003
Operating Income Ratio 0.0360.0490.012-0.0030.0130.027-0.015-0.0730.1250.1770.1710.2230.2170.2220.1180.019-0.0770.0230.0500.0330.0820.0770.1290.079000
Total Other Income Expenses Net -124.1-58.1-60.9-53-40.9-32.6-8.9-9-1.2-11.55824.817-177.336-16.6-20-33.17.495-27.5-21.7-40.333.7-27.3-27.2-43.6-0.0050-0.013
Income Before Tax -28.670.7-29.7-62.7-8.730.9-40-127.8319.2275.302419.7554.6391.7327.182163.79-89.828.29348.3-21.610.6-368.12494.5190.483.2-0.024-0.004-0.017
Income Before Tax Ratio -0.0110.027-0.011-0.021-0.0030.013-0.019-0.0790.1250.170.1810.230.2080.2270.1070.006-0.1230.0310.032-0.0160.0070.0750.060.1130.052000
Income Tax Expense 6.323.5-1.6-11.50.219.6-8.3-27.782.164.427111.3140.798.982.50241.15.1-23.711.23614.5-73.8-33.727.327.243.6-0.0050-0.013
Net Income -25.547.9-25-48.8-6.813.481-30.2-98.3237.9210.875308.4413.9292.8244.68122.63.9-66.117.05733.8-14.66.8-368.12494.5190.483.2-0.024-0.004-0.017
Net Income Ratio -0.0090.018-0.009-0.017-0.0030.006-0.014-0.0610.0930.130.1330.1720.1560.170.080.003-0.090.0190.022-0.0110.0040.0750.060.1130.052000
EPS -1.372.53-1.34-2.61-0.360.72-1.62-5.3612.7411.2916.5122.1615.6813.16.560.21-3.540.921.81-0.780.36-19.825.0610.194.45-0.49-0.08-0.33
EPS Diluted -1.372.53-1.34-2.61-0.360.72-1.62-5.2612.6911.2916.5122.1615.6813.16.560.21-3.540.921.81-0.780.36-19.825.0610.194.45-0.49-0.08-0.33
EBITDA 168.9189.289.247.1112.7109.9-11.8-101.5348.1282.965462.7609.8445358.832219.670.4-16.161.621117.341.691.8-466.223164.4260.6170.4-0.0050-0.013
EBITDA Ratio 0.0630.0720.0330.0160.0440.046-0.006-0.0630.1360.1750.20.2530.2360.2490.1440.047-0.0220.0680.0780.030.0590.0960.1040.1550.106000